A Case of Prolonged Hypogammaglobulinemia after Rituximab-Containing Chemotherapy in a Patient with Lymphoma |
Noh, Hyun Jin
(Departments of Internal Medicine, The Catholic University of Korea College of Medicine)
Gong, Bong Han (Departments of Internal Medicine, The Catholic University of Korea College of Medicine) Kim, Young Sin (Departments of Internal Medicine, The Catholic University of Korea College of Medicine) Jung, Yun Hwa (Departments of Internal Medicine, The Catholic University of Korea College of Medicine) Woo, In Sook (Departments of Internal Medicine, The Catholic University of Korea College of Medicine) Han, Chi Wha (Departments of Internal Medicine, The Catholic University of Korea College of Medicine) |
1 | Hicks LK, Woods A, Buckstein R, et al. Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma. Bone Marrow Transplant 2009;43:701-708. DOI ScienceOn |
2 | Kurokawa T, Hase M, Tokuman N, Yoshida T. Immune reconstitution of B-cell lymphoma patients receiving CHOP-based chemotherapy containing rituximab. Hematol Oncol 2011;29:5-9. DOI ScienceOn |
3 | Abulayha AM, Tabal SA, Shawesh EI, et al. Depletion of peripheral blood B cells with Rituximab and phenotype characterization of the recovering population in a patient with follicular lymphoma. Leuk Res 2010;34:307-311. DOI ScienceOn |
4 | Nishio M, Endo T, Fujimoto K, et al. FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation. Eur J Haematol 2009;82:143-147. DOI ScienceOn |
5 | Capolunghi F, Rosado MM, Sinibaldi M, Aranburu A, Carsetti R. Why do we need IgM memory B cells? Immunol Lett 2013;152:114-120. DOI ScienceOn |
6 | Walker AR, Kleiner A, Rich L, et al. Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma. Cancer Invest 2008;26:431-433. DOI ScienceOn |
7 | Casulo C, Maragulia J, Zelenetz AD. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections. Clin Lymphoma Myeloma Leuk 2013;13:106-111. DOI ScienceOn |
8 | Walewski J, Kraszewska E, Mioduszewska O, et al. Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study. Med Oncol 2001;18:141-148. DOI ScienceOn |
9 | Anolik JH, Friedberg JW, Zheng B, et al. B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny. Clin Immunol 2007;122:139-145. DOI ScienceOn |
10 | Avanzini MA, Locatelli F, Dos Santos C, et al. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. Exp Hematol 2005;33:480-486. DOI ScienceOn |